Alder BioPharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It discovers, develops, and commercializes therapeutic antibodies to transform the treatment paradigm for patients with migraine in the United States, Australia, and Ireland.
Take a look at the 1-year chart of Alder (NASDAQ: ALDR) below with the added notations:
Over the course of the past 5 months, ALDR has formed an important level to watch at $12. That mark has been support multiple times since October, while also having been resistance when the stock was beneath it.
The Tale of the Tape: ALDR has a key level at $12. A trader could enter a long position on a decline back down to that level with a stop placed under it. However, if traders are bearish on the stock, a short trade could be made instead on a break back below $12.
Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.
No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!
Christian Tharp, CMT